| Point of Care Diagnostics Market Soar Through End-use Industries and Push Revenues in Global by 2027 |
|
| According to MRFR analysis, the global point of care diagnostics/testing market is expected to register a CAGR of~11.6% from 2021 to 2027and hold a value of ~USD 36,740.3 million by 2027. Furthermore, the prominent players focus on employee satisfact |
| read more |
|
|
| Artificial Cervical Disc Market Size, Share, Manufacturing Growth, Demand and Trends to 2027 |
|
| The global artificial cervical disc market is driven by several factors, such as the increasing prevalence of orthopedic diseases and degenerative diseases, technological advancements in artificial discs, and the rise of a geriatric population in dev |
| read more |
|
|
| Chlamydia Infection Treatment Market Segmentation by Recent Trends, Development and Growth 2027 |
|
| According to the Centers for Disease Control and Prevention (CDC), the chlamydial infection has the highest prevalence in people aged ≤24 years in the US. Moreover, asymptomatic infection is also very common among people. Therefore, annual screenin |
| read more |
|
|
| Urinary Tract Infections Market Set to Witness an Uptick Forecast till 2027 |
|
| The historical impact of these drivers and restraints is analyzed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period. Various components of the glo |
| read more |
|
|
| Bariatric Surgery Devices Market Analysis, by Production, Gross Margin and Trends Forecast 2027 |
|
| Bariatric surgeries are procedures used for reducing stomach size by using different methods. It is extensively used for weight loss and is likely to benefit from the increasing prevalence of obesity. Technological developments are poised to dictate |
| read more |
|
|
| Biomarkers Market to Increase from Top End-use Industries During the Forecast to 2027 |
|
| Biomarkers are identifiers of diseases manifested within the body by the body’s natural reaction with the respective disease. The global market for biomarkers has been mainly driven by the growing medical research sector around the world, including |
| read more |
|
|
